ES8505666A1 - Procedimiento para preparar derivados de piperazina. - Google Patents
Procedimiento para preparar derivados de piperazina.Info
- Publication number
- ES8505666A1 ES8505666A1 ES522037A ES522037A ES8505666A1 ES 8505666 A1 ES8505666 A1 ES 8505666A1 ES 522037 A ES522037 A ES 522037A ES 522037 A ES522037 A ES 522037A ES 8505666 A1 ES8505666 A1 ES 8505666A1
- Authority
- ES
- Spain
- Prior art keywords
- antiatherosclerotic
- piperazine derivatives
- pyrazinyl
- piperazinethiocarboxanilide
- piperazinethiocarboxamides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000879 anti-atherosclerotic effect Effects 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- WMAMHPZDNSKTLX-UHFFFAOYSA-N 2-oxo-2-piperazin-1-ylacetamide Chemical class NC(=O)C(=O)N1CCNCC1 WMAMHPZDNSKTLX-UHFFFAOYSA-N 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- PVIJLUXKGBJNNI-UHFFFAOYSA-N piperazine-1-carbothioamide Chemical class NC(=S)N1CCNCC1 PVIJLUXKGBJNNI-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/375,507 US4439606A (en) | 1982-05-06 | 1982-05-06 | Antiatherosclerotic 1-piperazinecarbonyl compounds |
| US06/375,526 US4450272A (en) | 1982-05-06 | 1982-05-06 | Antiatherosclerotic 1-piperazine-thicarboxamides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES522037A0 ES522037A0 (es) | 1985-06-01 |
| ES8505666A1 true ES8505666A1 (es) | 1985-06-01 |
Family
ID=27007085
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES522037A Expired ES8505666A1 (es) | 1982-05-06 | 1983-05-03 | Procedimiento para preparar derivados de piperazina. |
| ES535527A Expired ES8506682A1 (es) | 1982-05-06 | 1984-08-30 | Procedimiento para preparar derivados de piperazina |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES535527A Expired ES8506682A1 (es) | 1982-05-06 | 1984-08-30 | Procedimiento para preparar derivados de piperazina |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0094498A3 (Direct) |
| KR (1) | KR840004733A (Direct) |
| AU (1) | AU1425183A (Direct) |
| DD (1) | DD215543A5 (Direct) |
| DK (1) | DK202183A (Direct) |
| ES (2) | ES8505666A1 (Direct) |
| FI (1) | FI831550A7 (Direct) |
| GR (1) | GR78261B (Direct) |
| IL (1) | IL68304A0 (Direct) |
| NZ (1) | NZ204054A (Direct) |
| PL (1) | PL241807A1 (Direct) |
| PT (1) | PT76647A (Direct) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05507702A (ja) * | 1990-05-30 | 1993-11-04 | アメリカン・ホーム・プロダクツ・コーポレイション | 置換アリールスルホンアミド類およびベンズアミド類 |
| JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
| WO2005121094A1 (en) * | 2004-06-09 | 2005-12-22 | Pfizer Limited | Piperazine and piperidine derivatives as anti-hiv-agents |
| WO2008013622A2 (en) * | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| CN104379563B (zh) | 2012-04-10 | 2018-12-21 | 加利福尼亚大学董事会 | 用于治疗癌症的组合物和方法 |
| UY35464A (es) | 2013-03-15 | 2014-10-31 | Araxes Pharma Llc | Inhibidores covalentes de kras g12c. |
| TWI659021B (zh) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Ｋｒａｓ ｇ１２ｃ之抑制劑 |
| JO3556B1 (ar) | 2014-09-18 | 2020-07-05 | Araxes Pharma Llc | علاجات مدمجة لمعالجة السرطان |
| US10011600B2 (en) | 2014-09-25 | 2018-07-03 | Araxes Pharma Llc | Methods and compositions for inhibition of Ras |
| WO2016164675A1 (en) | 2015-04-10 | 2016-10-13 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| ES2856880T3 (es) | 2015-04-15 | 2021-09-28 | Araxes Pharma Llc | Inhibidores tricíclicos condensados de KRAS y métodos de uso de los mismos |
| US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| WO2017058902A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| EP3356349A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| US10730867B2 (en) | 2015-09-28 | 2020-08-04 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3356347A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| WO2017058728A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| US10647703B2 (en) | 2015-09-28 | 2020-05-12 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3356359B1 (en) | 2015-09-28 | 2021-10-20 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| CN108779097A (zh) | 2015-11-16 | 2018-11-09 | 亚瑞克西斯制药公司 | 包含取代的杂环基的2-取代的喹唑啉化合物及其使用方法 |
| US10822312B2 (en) | 2016-03-30 | 2020-11-03 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use |
| US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| US10280172B2 (en) | 2016-09-29 | 2019-05-07 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| CN110312711A (zh) | 2016-10-07 | 2019-10-08 | 亚瑞克西斯制药公司 | 作为ras抑制剂的杂环化合物及其使用方法 |
| WO2018140599A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| US11059819B2 (en) | 2017-01-26 | 2021-07-13 | Janssen Biotech, Inc. | Fused hetero-hetero bicyclic compounds and methods of use thereof |
| EP3573954A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| EP3573970A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
| US11279689B2 (en) | 2017-01-26 | 2022-03-22 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer |
| EP3630747A1 (en) | 2017-05-25 | 2020-04-08 | Araxes Pharma LLC | Quinazoline derivatives as modulators of mutant kras, hras or nras |
| AU2018271990A1 (en) | 2017-05-25 | 2019-12-12 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| WO2018218071A1 (en) | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Compounds and methods of use thereof for treatment of cancer |
| CN112584833A (zh) | 2018-08-01 | 2021-03-30 | 亚瑞克西斯制药公司 | 杂环螺化合物及其用于治疗癌症的使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2602792A (en) * | 1950-11-24 | 1952-07-08 | American Cyanamid Co | 1-carbocycliccarbamyl-4-heterocyclic-piperazines |
| US2666055A (en) * | 1952-10-27 | 1954-01-12 | American Cyanamid Co | 1-thiocarbamyl-4-heterocyclic piperazines |
| DE1077218B (de) * | 1955-05-11 | 1960-03-10 | American Cyanamid Co | Verfahren zur Herstellung von gegen Hakenwurminfektionen wirksamen N, N-disubstituierten Piperazinen |
| CH583232A5 (Direct) * | 1973-02-02 | 1976-12-31 | Wander Ag Dr A | |
| FI193974A7 (Direct) * | 1973-07-13 | 1975-01-14 | Merck & Co Inc | |
| SE421695B (sv) * | 1975-04-21 | 1982-01-25 | Merck & Co Inc | Sett att framstella piperazinylpyraziner |
-
1983
- 1983-03-28 EP EP83103048A patent/EP0094498A3/en not_active Withdrawn
- 1983-04-06 IL IL68304A patent/IL68304A0/xx unknown
- 1983-04-28 GR GR71262A patent/GR78261B/el unknown
- 1983-04-29 NZ NZ204054A patent/NZ204054A/en unknown
- 1983-05-03 ES ES522037A patent/ES8505666A1/es not_active Expired
- 1983-05-04 KR KR1019830001906A patent/KR840004733A/ko not_active Withdrawn
- 1983-05-05 PT PT76647A patent/PT76647A/pt unknown
- 1983-05-05 DK DK202183A patent/DK202183A/da not_active Application Discontinuation
- 1983-05-05 AU AU14251/83A patent/AU1425183A/en not_active Abandoned
- 1983-05-05 FI FI831550A patent/FI831550A7/fi not_active Application Discontinuation
- 1983-05-05 PL PL24180783A patent/PL241807A1/xx unknown
- 1983-05-05 DD DD83250661A patent/DD215543A5/de unknown
-
1984
- 1984-08-30 ES ES535527A patent/ES8506682A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PL241807A1 (en) | 1986-02-11 |
| GR78261B (Direct) | 1984-09-26 |
| DK202183A (da) | 1983-11-07 |
| EP0094498A2 (en) | 1983-11-23 |
| PT76647A (en) | 1983-06-01 |
| KR840004733A (ko) | 1984-10-24 |
| DK202183D0 (da) | 1983-05-05 |
| ES522037A0 (es) | 1985-06-01 |
| ES535527A0 (es) | 1985-07-16 |
| IL68304A0 (en) | 1983-07-31 |
| ES8506682A1 (es) | 1985-07-16 |
| FI831550A7 (fi) | 1983-11-07 |
| NZ204054A (en) | 1987-04-30 |
| EP0094498A3 (en) | 1985-04-03 |
| AU1425183A (en) | 1983-11-10 |
| DD215543A5 (de) | 1984-11-14 |
| FI831550A0 (fi) | 1983-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8506682A1 (es) | Procedimiento para preparar derivados de piperazina | |
| PL240871A1 (en) | Process for preparing novel derivatives of 1,2,4-triazine and pyrazine | |
| IL63839A (en) | N-hetero-aryl-benzamides and benzcarbothioamides,process for their preparation,herbicidal compositions containing them and method of using them | |
| AU581772B2 (en) | Method for highly efficient laundering of textiles | |
| ZA853571B (en) | Compositions and process for treating textiles | |
| GB2033906B (en) | Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them | |
| PL245404A1 (en) | Process for preparing novel derivatives of 1,4:3,6-dianhydrohexites | |
| FR2510997B1 (Direct) | ||
| EP0226250A3 (en) | Process for the preparation of a polysaccharide in oil dispersion and dispersion obtained thereof | |
| BG42003A3 (en) | Method for preparing pyridyl compounds | |
| PL243409A1 (en) | Process for preparing novel derivatives of 1,2,4-triazole | |
| IL75086A0 (en) | 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,its production and pharmaceutical compositions containing it | |
| MY107160A (en) | N-aryl-3-aryl-4-substituted-4,5-dihydro-1h-pyrazole-1- carboxamides and processes for their production. | |
| YU44524B (en) | Process for obtaining derivatives of 3,4-dihydro-2h-benzopyrans | |
| HUT36076A (en) | Improved process for production of 1,8-dihidroxi-10-acil-9-antrons | |
| BG41129A3 (en) | Method for preparing acetamide derivatives | |
| PL249636A1 (en) | Process for preparing novel deriavatives of 8-alkoxycarbonyl-amino-4-aryl-3-methyl-1,2,3,4-tetrahydroisoquinoline | |
| ES450095A1 (es) | Procedimiento para la preparacion de 2-cloro-n-isopropil-2',3'-dimetilicetanilida. | |
| AU1374183A (en) | New cyanoguanidines, method for obtaining them and pharmac- eutical compositions containing them | |
| YU42909B (en) | Process for preparation of 2-(2-fluoro-4-trifluoro-methyl-phenyl) 1,3 di(1,2,4-triazole-1-ile)-2-propanol | |
| ES8605460A1 (es) | Procedimiento para la obtencion de hidrocarburos percloro- fluorados | |
| SU1089799A1 (ru) | Способ очистки газов от сернистых соединений | |
| SU1072420A1 (ru) | Бис-[(3,5-ди-трет-бутил-4-оксифенил)-алкил]-сульфиды в качестве термостабилизаторов полиэтилена | |
| DE3165793D1 (en) | Solvated salts of 2,4-dinitrophenyl cyanamides, process for preparing them and their application | |
| PL236659A1 (en) | Process for preparing 3,5-substituted derivatives of 2-thiohydantoin |